Articles by Waseem Noor - Pharmaceutical Executive

ADVERTISEMENT

Articles by Waseem Noor

Pharm Exec's Pharma 50 2014

Jun 9, 2014

For those companies in this year's Pharm Exec Top 50, meeting the accelerating market demand for specialty products has become an acute strategic imperative.

The 2013 Pharm Exec Top 50

May 1, 2013

Patent expiries dampen revenues for some of the biggest Big Pharma, but growth continues unabated for a few nimble "stealth" players moving steadily up the list.

2013 Pharm Exec Top 50

May 1, 2013

Patent expiries dampen revenues for some of the biggest Big Pharma, but growth continues unabated for a few nimble "stealth" players moving steadily up the list.

Toolkit: How To Be a Better Partner

Big pharmas and little biotechs have been getting hitched for years. Now it's time to add a little innovation to the relationship. Three new rules will keep the game exciting.
May 1, 2007

Pharma industry alliances are increasingly critical to success. They are gaining on R&D in terms of importance, especially since many companies are falling short in their internal pipelines and need to look outside for promising compounds. Today, nearly two-thirds of the top 20 pharma and biotech companies have established alliance-management functions. These usually cover deals in the discovery, development, and marketing space.

ADVERTISEMENT

Click here